AR045141A1 - Sales de tartrato de 2- metoximetil-3-(3,4-diclorofenil)-8-azabiciclo (3,2,1) octano. composiciones farmaceuticas que los contienen y usos de las mismas. - Google Patents
Sales de tartrato de 2- metoximetil-3-(3,4-diclorofenil)-8-azabiciclo (3,2,1) octano. composiciones farmaceuticas que los contienen y usos de las mismas.Info
- Publication number
- AR045141A1 AR045141A1 ARP040102679A ARP040102679A AR045141A1 AR 045141 A1 AR045141 A1 AR 045141A1 AR P040102679 A ARP040102679 A AR P040102679A AR P040102679 A ARP040102679 A AR P040102679A AR 045141 A1 AR045141 A1 AR 045141A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical compositions
- metoximetil
- diclorofenil
- azabiciclo
- octano
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Las sales son inhibidores de re-captación de neurotransmisores monoamina. En otros aspectos, la presente se relaciona con el uso de estas sales en un método de terapia y con composiciones farmacéuticas que incluyen las sales del presente. Reivindicación 1: Una sal seleccionada de las formas anhidras e hidradas de tartrato de (1R,2R,3S,5S)-2-metoximetil-3-(3,4-diclorofenil)-8-azabiciclo[3,2,1]octano.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200301117 | 2003-07-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR045141A1 true AR045141A1 (es) | 2005-10-19 |
Family
ID=36701727
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040102679A AR045141A1 (es) | 2003-07-31 | 2004-07-28 | Sales de tartrato de 2- metoximetil-3-(3,4-diclorofenil)-8-azabiciclo (3,2,1) octano. composiciones farmaceuticas que los contienen y usos de las mismas. |
Country Status (22)
Country | Link |
---|---|
US (1) | US7700619B2 (es) |
EP (1) | EP1651223B1 (es) |
JP (1) | JP4711961B2 (es) |
CN (1) | CN100427484C (es) |
AR (1) | AR045141A1 (es) |
AT (1) | ATE355060T1 (es) |
AU (1) | AU2004260837C1 (es) |
BR (1) | BRPI0413035A (es) |
CA (1) | CA2534295A1 (es) |
DE (1) | DE602004005048T2 (es) |
DK (1) | DK1651223T3 (es) |
ES (1) | ES2281827T3 (es) |
MY (1) | MY140105A (es) |
NZ (1) | NZ544957A (es) |
PL (1) | PL1651223T3 (es) |
PT (1) | PT1651223E (es) |
RU (1) | RU2348631C2 (es) |
SI (1) | SI1651223T1 (es) |
TW (1) | TW200507844A (es) |
UA (1) | UA86025C2 (es) |
WO (1) | WO2005011694A1 (es) |
ZA (1) | ZA200600756B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2614833A1 (en) * | 2005-07-12 | 2007-01-18 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition comprising 2, 3-disubstituted tropanes for the treatment of disorders of sexual desire |
WO2007028769A1 (en) * | 2005-09-05 | 2007-03-15 | Neurosearch A/S | Monoamine neurotransmitter re-uptake inhibitor for neuroprotection |
EP1779851A1 (en) * | 2005-10-31 | 2007-05-02 | Boehringer Ingelheim Pharma GmbH & Co.KG | Treatment of diabetes |
GB0703998D0 (en) * | 2007-03-01 | 2007-04-11 | Glaxo Group Ltd | Novel salt |
CN116144016A (zh) * | 2021-11-23 | 2023-05-23 | 上海新阳半导体材料股份有限公司 | 一种193nm干法光刻胶用添加剂及其制备方法和应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8923209D0 (en) * | 1989-10-14 | 1989-11-29 | Wyeth John & Brother Ltd | Heterocyclic compounds |
ATE203023T1 (de) * | 1996-02-22 | 2001-07-15 | Neurosearch As | Tropanderivate, deren herstellung und verwendung |
ATE345135T1 (de) | 2001-11-30 | 2006-12-15 | Neurosearch As | Tropan-derivate mit dopamin-wiederaufnahme-hemmer-wirkung für die behandlung von ischämischen erkrankungen |
-
2004
- 2004-07-28 AR ARP040102679A patent/AR045141A1/es not_active Application Discontinuation
- 2004-07-29 RU RU2005141065/04A patent/RU2348631C2/ru not_active IP Right Cessation
- 2004-07-29 PT PT04766360T patent/PT1651223E/pt unknown
- 2004-07-29 ES ES04766360T patent/ES2281827T3/es not_active Expired - Lifetime
- 2004-07-29 JP JP2006521585A patent/JP4711961B2/ja not_active Expired - Fee Related
- 2004-07-29 TW TW093122661A patent/TW200507844A/zh unknown
- 2004-07-29 DE DE602004005048T patent/DE602004005048T2/de not_active Expired - Lifetime
- 2004-07-29 AU AU2004260837A patent/AU2004260837C1/en not_active Ceased
- 2004-07-29 PL PL04766360T patent/PL1651223T3/pl unknown
- 2004-07-29 DK DK04766360T patent/DK1651223T3/da active
- 2004-07-29 ZA ZA200600756A patent/ZA200600756B/en unknown
- 2004-07-29 US US10/566,384 patent/US7700619B2/en not_active Expired - Fee Related
- 2004-07-29 CA CA002534295A patent/CA2534295A1/en not_active Abandoned
- 2004-07-29 CN CNB2004800198958A patent/CN100427484C/zh not_active Expired - Fee Related
- 2004-07-29 AT AT04766360T patent/ATE355060T1/de not_active IP Right Cessation
- 2004-07-29 NZ NZ544957A patent/NZ544957A/en unknown
- 2004-07-29 SI SI200430267T patent/SI1651223T1/sl unknown
- 2004-07-29 BR BRPI0413035-9A patent/BRPI0413035A/pt not_active Application Discontinuation
- 2004-07-29 EP EP04766360A patent/EP1651223B1/en not_active Expired - Lifetime
- 2004-07-29 UA UAA200600268A patent/UA86025C2/ru unknown
- 2004-07-29 WO PCT/EP2004/051651 patent/WO2005011694A1/en active IP Right Grant
- 2004-07-30 MY MYPI20043081A patent/MY140105A/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE602004005048D1 (de) | 2007-04-12 |
EP1651223A1 (en) | 2006-05-03 |
JP4711961B2 (ja) | 2011-06-29 |
WO2005011694A1 (en) | 2005-02-10 |
JP2007509030A (ja) | 2007-04-12 |
MY140105A (en) | 2009-11-30 |
CN1822837A (zh) | 2006-08-23 |
DE602004005048T2 (de) | 2007-08-16 |
ATE355060T1 (de) | 2006-03-15 |
TW200507844A (en) | 2005-03-01 |
RU2005141065A (ru) | 2006-08-10 |
ZA200600756B (en) | 2007-05-30 |
CN100427484C (zh) | 2008-10-22 |
RU2348631C2 (ru) | 2009-03-10 |
CA2534295A1 (en) | 2005-02-10 |
US20070043075A1 (en) | 2007-02-22 |
UA86025C2 (en) | 2009-03-25 |
US7700619B2 (en) | 2010-04-20 |
ES2281827T3 (es) | 2007-10-01 |
AU2004260837A1 (en) | 2005-02-10 |
AU2004260837C1 (en) | 2010-08-19 |
DK1651223T3 (da) | 2007-06-11 |
EP1651223B1 (en) | 2007-02-28 |
PL1651223T3 (pl) | 2007-07-31 |
PT1651223E (pt) | 2007-03-30 |
SI1651223T1 (sl) | 2007-08-31 |
NZ544957A (en) | 2009-02-28 |
BRPI0413035A (pt) | 2006-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200800514A1 (ru) | Замещённые 7-азаиндазолы, содержащие их композиции, способ получения и применения | |
PE20081649A1 (es) | Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos | |
PE20142371A1 (es) | Combinacion farmaceutica de 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol y un antiepileptico | |
CR7583A (es) | Nueva sal formiato de o-desmetil venlafaxina | |
UY27712A1 (es) | Indazoles sustituidos, composiciones que los contienen, procedimientos de fabricación y utilización | |
UY28215A1 (es) | Quinazolinas utiles como moduladores de canales iónicos | |
UY30481A1 (es) | Isoxazolinas sustituidas, composiciones farmaccuticas que contienen a las mismas, metodos de preparacion y usos. | |
UY29087A1 (es) | Derivados de adamantilo, composiciones farmaceuticas que los contienen, procesos para su preparacion y uso terapeutico | |
PA8587101A1 (es) | Nuevos derivados de dihidropirimido [4,5-d] pirimidinona sustituida por amiino, fabricacion y uso de los mismos como agentes farmaceuticos | |
ECSP11011327A (es) | Derivados de aminotetralina, composiciones farmacéuticas que los contienen, y sus usos en terapia | |
UY27740A1 (es) | Nuevos compuestos | |
AR054347A1 (es) | Combinaciones terapeuticas para el tratamiento o la prevencion de la depresion | |
SV2007002526A (es) | Diarilsulfona sulfonamidas y el uso de las mismas ref. p1018 | |
PA8606201A1 (es) | DERIVADOS DE PIRROLO[3,4-c) PIRAZOL ACTIVOS COMO INHIBIDORES DE QUINASA, PROCESO PARA SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LOS COMPRENDEN | |
PA8594801A1 (es) | Formulaciones farmaceuticas liquidas de palanosetron | |
CY1110341T1 (el) | Παραγωγα κιναζολινης και η χρηση τους στην θεραπευτικη αγωγη θρομβοκυτταραιμιας | |
UY30289A1 (es) | Derivados de la 1h-pirrol-3-carboxamida sustituida con 1-(tetrahidro-2h-piran-4-il-metil)-1h-bencimidazol, composiciones conteniéndolos, procedimientos de preparacion y aplicaciones | |
CL2007000945A1 (es) | Formulacion farmaceutica que comprende una sal cristalina de monohidrato de hidrocloruro de (5s,8s)-8-[[(1r)-1-(3,5-bistrifluorometil)fenil]-etoximetil]-8-fenil-1,7-diaza-espiro[4.5]decan-2-ona; capsula que la contiene; y uso en el tratamiento de la emesis y nausea. | |
AR024998A1 (es) | Nuevos retinoides para el tratamiento del enfisema | |
UY28356A1 (es) | Derivados de benzimidazol, composiciones que los contienen, preparaciones de los mismos y sus usos | |
EA201591904A1 (ru) | НОВЫЕ ПРОИЗВОДНЫЕ N-(2,3-ДИГИДРО-1H-ПИРРОЛО[2,3-b]ПИРИДИН-5-ИЛ)-4-ХИНАЗОЛИНАМИНА И N-(2,3-ДИГИДРО-1H-ИНДОЛ-5-ИЛ)-4-ХИНАЗОЛИНАМИНА В КАЧЕСТВЕ ИНГИБИТОРОВ PERK | |
AR045141A1 (es) | Sales de tartrato de 2- metoximetil-3-(3,4-diclorofenil)-8-azabiciclo (3,2,1) octano. composiciones farmaceuticas que los contienen y usos de las mismas. | |
UY28357A1 (es) | Derivados de benzimidazol, composiciones que los contienen, preparación de los mismos y sus usos | |
PE20240885A1 (es) | Sales agonistas de sstr4 | |
UY28535A1 (es) | Derivados de bencimidazol, composiciones que los contienen, preparacion y usos de los mismos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |